Azadeh Kia

发表

ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2

Robert H. Brown, P. Pasinelli, D. Trotti, 2010, Human molecular genetics.

Dual Systemic Tumor Targeting with Ligand-Directed Phage and Grp78 Promoter Induces Tumor Regression

N. Mazarakis, A. Hajitou, N. Nianiaris, 2012, Molecular Cancer Therapeutics.

Therapeutic Discovery Dual Systemic Tumor Targeting with Ligand-Directed Phage and Grp 78 Promoter Induces Tumor Regression

N. Mazarakis, A. Hajitou, N. Nianiaris, 2012 .

Liver-Directed AAV Gene Therapy for Gaucher Disease

Rose M. Sheridan, R. Corbau, E. Chisari, 2019, Blood.

Liver-directed gene therapy corrects Fabry disease in mice

Rose M. Sheridan, R. Corbau, A. Nathwani, 2019, Molecular Genetics and Metabolism.

Crosslinking of DNA repair and replication proteins to DNA in cells treated with 6-thioguanine and UVA

David Frith, P. Karran, Peter Karran, 2011, Nucleic acids research.

First-in-human study of a liver-directed AAV gene therapy (FLT190) in Fabry disease

Rose M. Sheridan, R. Corbau, D. Hughes, 2020 .

Preferential targeting of disseminated liver tumors using a recombinant adeno-associated viral vector.

M. Lythgoe, Roger Williams, A. Davidoff, 2015, Human gene therapy.

Astrocytes expressing ALS‐linked mutant FUS induce motor neuron death through release of tumor necrosis factor‐alpha

K. Krishnamurthy, P. Pasinelli, D. Trotti, 2018, Glia.

Inhibition of Histone Deacetylation and DNA Methylation Improves Gene Expression Mediated by the Adeno-Associated Virus/Phage in Cancer Cells

N. Hajji, A. Hajitou, Teerapong Yata, 2013, Viruses.

Preclinical evaluation of FLT190, a liver-directed AAV gene therapy for Fabry disease

Rose M. Sheridan, W. Heywood, K. Mills, 2023, Gene Therapy.